AllianceBernstein’s Tango Therapeutics TNGX Stock Holding History

AllianceBernstein’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.04M	Buy	117,620 +11,130	+10%	+$155K	﹤0.01%	2327
2025 Q4	$944K	Buy	106,490 +4,220	+4%	+$36.4K	﹤0.01%	2373
2025 Q3	$859K	Sell	102,270 -3,740	-4%	-$25.3K	﹤0.01%	2414
2025 Q2	$543K	Buy	106,010 +41,070	+63%	+$102K	﹤0.01%	2593
2025 Q1	$89K	Hold	64,940	–	–	﹤0.01%	3080
2024 Q4	$201K	Hold	64,940	–	–	﹤0.01%	3023
2024 Q3	$500K	Hold	64,940	–	–	﹤0.01%	2663
2024 Q2	$557K	Buy	64,940 +16,980	+35%	+$131K	﹤0.01%	2617
2024 Q1	$381K	Buy	47,960 +11,320	+31%	+$121K	﹤0.01%	2710
2023 Q4	$363K	Buy	36,640 +8,480	+30%	+$73.6K	﹤0.01%	2763
2023 Q3	$317K	Hold	28,160	–	–	﹤0.01%	2784
2023 Q2	$93.5K	Buy	28,160 +12,360	+78%	+$44.5K	﹤0.01%	3086
2023 Q1	$62.4K	Buy	15,800 +2,800	+22%	+$16.3K	﹤0.01%	3078
2022 Q4	$94.3K	Buy	+13,000	New	+$91.4K	﹤0.01%	3118

Other funds holding TNGX

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

TGI

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

AllianceBernstein's TNGX Position: Q1 2026 in Review

AllianceBernstein increased its Tango Therapeutics (TNGX) stake by 10% in Q1 2026, buying an estimated $155K and bringing the position to 117,620 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #2327.

AllianceBernstein first reported a position in TNGX in Q4 2022 and has held it in 14 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

AllianceBernstein held 117,620 shares of Tango Therapeutics worth $1.04M as of Q1 2026.
AllianceBernstein bought 11,130 Tango Therapeutics shares in Q1 2026, an estimated $155K.
Tango Therapeutics made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #2327 holding.
AllianceBernstein first reported a position in Tango Therapeutics in Q4 2022 and has held it in 14 quarters since.
194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.